Pregnancy Nutrition Trial Finds Greater Growth

Medically reviewed | Published: | Evidence level: 1A
A randomized trial involving 215 pregnant women in Ecuador found that a locally adapted nutrition program improved dietary diversity and increased growth in a specific fetal brain region. The findings support further investigation of food-based prenatal interventions, but do not establish better childhood intelligence or development.
📅 Published:
Reviewed by iMedic Medical Editorial Team
📄 Research

Quick Facts

Trial Size
215 pregnant women
Program Start
Around 12 weeks pregnant
Food Deliveries
Once weekly

What did the pregnancy nutrition trial test?

Quick answer: The Mikhuna trial tested whether regular food deliveries and dietary guidance could improve maternal nutrition and fetal development alongside standard prenatal care.

Researchers assigned 111 women to the nutrition program and 104 to a comparison group in two communities near Quito. Beginning around 12 weeks of pregnancy, participants receiving the intervention were supplied with eggs, fish, fruits and vegetables each week until birth. Guidance encouraged greater food variety and less reliance on highly processed products. The approach drew on ancestral dietary research while using foods available locally. [Washington University study announcement](https://source.washu.edu/2026/09/pregnancy-nutrition-trial-in-ecuador-improves-fetal-brain-growth/)

The registered protocol specified standard prenatal supplements, including iron–folic acid and calcium, for both groups. This design examined the additional contribution of food and nutrition support. Because the intervention combined food provision with education, its results cannot establish whether counseling alone would produce comparable changes. [ClinicalTrials.gov trial registration](https://clinicaltrials.gov/study/NCT05242224)

What changed in fetal brain growth, and how convincing is the evidence?

Quick answer: Growth in the gangliothalamic ovoid increased, but the finding concerns an ultrasound measurement whose long-term developmental significance remains uncertain.

Between 21 and 35 weeks, the intervention group showed 0.15 centimeters greater growth in gangliothalamic ovoid height. This region includes structures involved in movement, sensory processing and cognition. The difference remained statistically significant after adjustment for multiple comparisons, a safeguard against chance findings when researchers examine several outcomes. Initial findings involving greater corpus callosum growth and less femur growth did not survive that adjustment. Newborn size measures showed no significant group differences. [Published PNAS trial](https://www.pnas.org/doi/10.1073/pnas.2602218123)

Interpretation requires caution: 19.5% of participants were lost to follow-up, and measurement reliability varied, particularly for smaller brain structures. The study did not establish improved childhood cognition. Larger studies with longer developmental follow-up are needed before these imaging changes can be treated as evidence of lasting clinical benefit.

How could these findings influence prenatal nutrition care?

Quick answer: The trial supports further research into practical food support during pregnancy while established prenatal nutrition recommendations remain the foundation of care.

By the end of the intervention, 74.5% of participants receiving food support met the study's minimum dietary diversity threshold, compared with 55.8% of controls. One practical implication is that making nutritious foods accessible may deserve attention alongside dietary advice. However, the combined intervention does not reveal which food, nutrient or program component produced the brain finding. [Washington University findings](https://source.washu.edu/2026/09/pregnancy-nutrition-trial-in-ecuador-improves-fetal-brain-growth/)

Established care already addresses nutritional deficiencies during pregnancy. WHO recommends daily iron and folic acid supplementation to help prevent maternal anemia and adverse birth outcomes, with folic acid started as early as possible, ideally before conception, to prevent neural tube defects. The new trial provides no basis for stopping prescribed supplements or increasing doses to pursue fetal brain growth. Supplement decisions should follow local antenatal guidance and individual clinical needs. [WHO pregnancy supplementation recommendations](https://www.who.int/tools/elena/interventions/daily-iron-pregnancy)

Frequently Asked Questions

No. It identified changes in fetal brain measurements, not improved intelligence, learning or behavior. Those outcomes require follow-up through childhood.

This trial did not test that approach. Both groups were assigned standard prenatal supplements, so its findings do not support replacing prescribed supplementation with dietary changes.

No. Mikhuna was a randomized clinical trial of food provision and nutrition guidance added to prenatal care.

References

  1. Iannotti LL, et al. Pregnancy diet based on ancestral patterns increases growth in subcortical fetal brain regions. Proceedings of the National Academy of Sciences. 2026;123(36):e2602218123. https://doi.org/10.1073/pnas.2602218123
  2. Washington University in St. Louis. Pregnancy nutrition trial in Ecuador improves fetal brain growth. September 15, 2026. https://source.washu.edu/2026/09/pregnancy-nutrition-trial-in-ecuador-improves-fetal-brain-growth/
  3. ClinicalTrials.gov. Evolutionary Nutrition Pilot: Enhancing Fetal Growth and Brain Development. NCT05242224. https://clinicaltrials.gov/study/NCT05242224
  4. World Health Organization. Daily iron and folic acid supplementation during pregnancy. Updated July 26, 2024. https://www.who.int/tools/elena/interventions/daily-iron-pregnancy